Resources
BNET Resources
- sort by:
- Relevance
- Date
- Popularity
- Boston-Area Firms Gain Little from War.
- By Christopher Rowland, The Boston Globe Knight Ridder/Tribune Business News Apr. 7--The stench of heated bacteria growth medium, zapped in a microwave to a temperature of 121 degrees, fills a windowless laboratory at Avant Immunotherapeutics in Needham. To a visitor, the odor is...
- Research articles 2003-04-07
- Boston Area Unclear How Long, How Seriously War Will Effect Economy.
- The Boston Globe Knight Ridder/Tribune Business News Feb. 16--A war with Iraq will do harm to the Boston economy. It's only a question of how deep, how long, and where the damage will be greatest. From healthcare, technology, and real estate...
- Research articles 2003-02-16
- AVANT CEO to Present at the Needham & Company Biotechnology & Medical Technology Conference
- NEEDHAM, Mass. -- AVANT Immunotherapeutics, Inc. (Nasdaq: AVAN) today announced that Anthony S. Marucci, Interim President and Chief Executive Officer of AVANT Immunotherapeutics, Inc., will present at the Seventh Annual Needham & Company, LLC Biotechnology & Medical Technology Conference at the New York Palace Hotel in New York City on...
- Research articles 2008-06-04
- AVANT CEO Calls for Creation of National Biodefense Clearinghouse; Technology Exists to Provide Biotech Defense Products But Industry Needs Coordinated Support
- Business Editors & Health/Medical Writers
- Research articles 2002-02-05
- AVANT CEO to Present at the Needham & Company Biotechnology & Medical Technology Conference
- NEEDHAM, Mass. -- AVANT Immunotherapeutics, Inc. (Nasdaq:AVAN) today announced that Dr. Una S. Ryan, President and Chief Executive Officer of AVANT Immunotherapeutics, Inc., will present at the Needham & Company Sixth Annual Biotechnology & Medical Technology Conference at the New York Palace Hotel in New York City on Wednesday, June...
- Research articles 2007-06-06
- Avant CEO to Present at the Needham & Company Biotechnology Conference
- NEEDHAM, Mass. -- AVANT Immunotherapeutics, Inc. (Nasdaq: AVAN) today announced that Dr. Una S. Ryan, President and Chief Executive Officer of AVANT Immunotherapeutics, Inc., will present at the Needham & Company Fourth Annual Biotechnology Conference at the New York Palace Hotel in New York City on Wednesday, May 25th at...
- Research articles 2005-05-19
Additional Resources
- AVANT's CEO to Present at the BIO CEO & Investor Conference
- NEEDHAM, Mass. -- AVANT Immunotherapeutics, Inc. (Nasdaq: AVAN) announced today that Dr. Una S. Ryan, AVANT's President and CEO, will be presenting on Wednesday, February 23rd at 11:00 a.m. Eastern Time at the Biotechnology Industry Organization's BIO CEO & Investor Conference in New York City. This presentation will be webcast...
- Research articles 2005-02-18
- AVANT's CEO to Present at the BIO CEO & Investor Conference
- NEEDHAM, Mass. -- AVANT Immunotherapeutics, Inc. (Nasdaq: AVAN) announced today that Dr. Una S. Ryan, AVANT's President and CEO, will be presenting on Monday, February 12th at 2:45 p.m. Eastern Time at the Biotechnology Industry Organization's BIO CEO & Investor Conference in New York City. This presentation will be webcast...
- Research articles 2007-02-06
- AVANT To Present At 2005 BIO Investor Forum
- NEEDHAM, Mass. -- AVANT Immunotherapeutics, Inc. (Nasdaq: AVAN) today announced that Dr. Una S. Ryan, President and Chief Executive Officer of AVANT Immunotherapeutics, Inc., will present at the 2005 Biotechnology Industry Organization BIO Investor Forum on Wednesday October 19th at 2:40 p.m., PT. The conference is being held October 19-20,...
- Research articles 2005-10-13
- New Congressional Defense Bill Supports Development and Purchase of Vaccines to Meet the Nation's Public Health Threats; AVANT Expects to Participate in the Development of New Vaccine Technologies to Meet These Threats
- NEEDHAM, Mass. -- AVANT Immunotherapeutics, Inc. (NASDAQ: AVAN) today announced that the new Congressional defense bill, which passed today and is expected to be signed by President Bush, will provide over $3 billion for the development and purchase of vaccines, antivirals and necessary medical equipment as well as for critical...
- Research articles 2005-12-22
- 20 Companies to Present at Biotechnology / Healthcare / Pharmaceuticals Forum in NYC on June 15
- RICHMOND, Va. -- Presenters Include Sanofi-Aventis ADS, AVANT Immunotherapeutics, Inc., Biosante Pharmaceuticals, Inc., Lorus Therapeutics, Samaritan Pharmaceuticals, Inc., Crucell N.V., and LMS Medical Systems, Inc. Current and prospective investors will hear top executives from 20 diverse companies in the Life Sciences field at the Informed Investors Biotechnology / Healthcare...
- Research articles 2005-05-26
- EmergingMarketsllc.com:Emerging Equity Alerts.
- M2 PRESSWIRE-22 March 2006-Emerging Markets Consulting, LLC.: EmergingMarketsllc.com:Emerging Equity AlertsC1994-2006 M2 COMMUNICATIONS LTD RDATE:22032006 Orlando, FL - Stocks gaining traction in Tuesday's trading included Generex Biotechnology Corp. (NASDAQ: GNBT), Mindspeed Technologies, Inc. (NASDAQ: MSPD), Bally Total Fitness (NYSE:BFT) and ...
- Research articles 2006-03-22
- << Previous
- page 1 of 1
- Next >>
Presented by American Express